China Bio-Pharmaceutical Market Study by CRI Now Available at MarketPublishers.com

Share Article

New market study “Research Report on Chinese Bio-Pharmaceutical Industry, 2012” drawn up by China Research and Intelligence (CRI) has been recently published by Market Publishers Ltd. The study finds that last year the sales revenue of the bio-pharmaceutical sector in China surpassed CNY 160 billion, accounting for less than 15% of the total sales revenue of pharmaceutical industry.

TD The Market Publishers Ltd

http://marketpublishers.com/

China’s biological product industry is an emerging one with just over twenty years of history. Last year, the sales revenue of the bio-pharmaceutical sector in China surpassed CNY 160 billion, accounting for less than 15% of the total sales revenue of pharmaceutical industry. The products are mostly concentrated in low-end generic vaccines, blood product industry, and technological barriers are not high. Also, the country’s bio-pharmaceutical industry is still mainly represented by small and medium-sized enterprises, and the market concentration rate is low.

However, driven by positive factors like rapid growth of Chinese economy, rising of residents' income and improving of residents' cognition and needs for biopharmaceuticals, the market of China’s bio-pharmaceutical industry is gradually enlarging and the status in the national economy is constantly improving, with the industry expected to eventually hold great investment potential going forward.

New market study “Research Report on Chinese Bio-Pharmaceutical Industry, 2012” drawn up by China Research and Intelligence (CRI) has been recently published by Market Publishers Ltd.

Report Details:

Title: Research Report on Chinese Bio-Pharmaceutical Industry, 2012
Published: March, 2012
Pages: 60
Price: US$ 3,000
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/drugs_biotechnology/research_report_on_chinese_bio_pharmaceutical_industry_2012.html

The study provides true and unprejudiced insights into China’s bio-pharmaceutical market, covering:

  •     current situation of Chinese bio-pharmaceutical industry;
  •     current situation of Chinese bio-pharmaceutical sub-industries;
  •     market competition of bio-pharmaceutical industry;
  •     import and export of bio-pharmaceutical industry;
  •     development trend of bio-pharmaceutical industry.

Report Contents:

1 Overview on Chinese Bio-Pharmaceutical Industry, 2011-2012

1.1 Development Overview on Bio-pharmaceutical Industry
1.1.1 Definition of Bio-pharmaceutical Industry
1.1.2 Characteristics of Bio-pharmaceutical Industry
1.1.3 Current Situation of Chinese Bio-pharmaceutical Industry
1.2 Analysis and Prediction on Supply of Chinese Bio-pharmaceutical Industry
1.2.1 Analysis on Gross Supply
1.2.2 Supply Structure
1.2.3 Supply Prediction, 2012-2016
1.3 Analysis and Prediction on Demand of Chinese Bio-pharmaceutical Industry
1.3.1 Gross Demand
1.3.2 Demand Structure

2 Analysis and Prediction on Competition of Chinese Bio-Pharmaceutical Industry, 2011-2016

2.1 Current Situation of Industry Competition
2.1.1 Barriers to Entry
2.1.2 Ferocious Market Competition
2.1.3 Competition Between Foreign-funded and Localized Pharmaceutical Companies
2.1.4 Competition Between Generic Drugs and Original Drugs
2.1.5 Other Competitions
2.2 Competition Characteristics
2.2.1 Increasing Concentration Rate of Company
2.2.2 Intensifying Supervision
2.3 Competition Structure (Michael Porter "Five Forces")
2.3.1 Potential Entrants
2.3.2 Competition in Existing Competitors
2.3.3 Suppliers' Bargaining Ability
2.3.4 Customers' Bargaining Ability
2.3.5 Substitutes
2.4 Analysis and Prediction on M&A of Chinese Bio-pharmaceutical Industry
2.4.1 Current Situation
2.4.2 Trend

3 Analysis on Sub-Industries of Chinese Bio-Pharmaceutical Industry, 2011-2012

3.1 Blood Products
3.2 Vaccine
3.3 Diagnostic Reagents
3.4 Genetic Recombination Drugs

4 Analysis and Prediction on Import and Export of Chinese Bio-Pharmaceutical Industry, 2011-2016

4.1 Import of Chinese Bio-pharmaceutical Industry
4.1.1 Overview
4.1.2 Import of Human Vaccines
4.1.3 Import of Human Blood Products and Medical Animal Blood Products
4.2 Export of Chinese Bio-pharmaceutical Industry
4.2.1 Overview
4.2.2 Export of Human Vaccines
4.2.3 Export of Human Blood Products and Medical Animal Blood Products
4.3 Prediction on Import and Export of Chinese Bio-pharmaceutical Industry

5 Analysis on Key Enterprises of Chinese Bio-Pharmaceutical Industry, 2011-2012

5.1 Hualan Biological Engineering Co., Ltd.
5.1.1 Corporate Profile
5.1.2 Operations
5.1.3 Development Strategies
5.2 Shanghai Kehua Biological Engineering Co., Ltd.
5.3 Beijing Tiantan Biological Products Co., Ltd.
5.4 Beijing SL Pharmaceutical Co., Ltd.
5.5 Daan Gene Co., Ltd.
5.6 Shanghai RAAS Blood Products Co., Ltd.
5.7 Chongqing Chifei Biological Products Co., Ltd.
5.8 Tonghua Dongbao Pharmaceutical Co., Ltd.

6 Factors Influencing Development of Chinese Bio-Pharmaceutical Industry

6.1 Economic Environment
6.1.1 International Economic Environment
6.1.2 Chinese Economy
6.1.3 Changing Exchange Rate
6.2 Policy Environment
6.2.1 Industrial Policy
6.2.2 Environmental Protection Policy
6.3 Market Risks
6.3.1 Risks of Market Demand and Supply
6.3.2 Price Risk

7 Prediction on Investment and Development of Chinese Bio-Pharmaceutical Industry, 2012-2016

7.1 Prediction on Development of Chinese Bio-pharmaceutical Industry
7.1.1 Prediction on Market Scale, 2012-2016
7.1.2 Prediction on Technological Level
7.2 Investment Opportunities of Bio-pharmaceutical Industry
7.2.1 Whole Investment Opportunities
7.2.2 Sub-industries Investment Opportunities
7.2.3 Regional Investment Opportunities
7.3 Investment Opportunities of Industries Related to Bio-pharmaceutical Industry
7.3.1 Pharmaceutical Commerce
7.3.2 Medical Machinery Industry

Selected Charts
...

More new market studies by the publisher can be found at CRI page.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tanya Rezler
Visit website